TREATMENT OF UPPER EXTREMITY DEEP VEIN THROMBOSIS (DVT)
上肢深静脉血栓 (DVT) 的治疗
基本信息
- 批准号:7608091
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2008-02-29
- 项目状态:已结题
- 来源:
- 关键词:Computer Retrieval of Information on Scientific Projects DatabaseDalteparinDalteparin SodiumDataDeep Vein ThrombosisDiagnosisFundingGrantHemorrhageIncidenceInjection of therapeutic agentInstitutionLow-Molecular-Weight HeparinOutcomePatientsPharmaceutical EconomicsPostphlebitic SyndromeRecurrenceResearchResearch PersonnelResourcesSourceThromboembolismUnited States National Institutes of HealthUpper ExtremityVenousWarfarinoutcome forecast
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
OBJECTIVE: To document the long-term outcome (prognosis) of patients diagnosed with upper extremity deep-vein thrombosis (DVT) who are treated with Fragmin (dalteparin sodium injection) followed by Warfarin for 3 months. Specific Aims1. To evaluate the incidence of recurrent venous thromboembolism in patients diagnosed with upper extremity DVT who are treated with Fragmin followed by Warfarin for 3 months.2. To evaluate the incidence of major bleeding in patients diagnosed with upper extremity DVT who are treated with Fragmin followed by Warfarin for 3 months.3. To evaluate the incidence of post-phlebitic syndrome at one year in patients with upper extremity DVT.4. To gather descriptive/demographic data on patients with upper extremity DVT.5. To perform a pharmacoeconomic assessment of treatment of upper extremity DVT using low molecular weight heparin.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUMAN W RATHBUN其他文献
SUMAN W RATHBUN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUMAN W RATHBUN', 18)}}的其他基金
TREATMENT OF UPPER EXTREMITY DEEP VEIN THROMBOSIS (DVT)
上肢深静脉血栓 (DVT) 的治疗
- 批准号:
7378103 - 财政年份:2006
- 资助金额:
$ 1.22万 - 项目类别:
TREATMENT OF UPPER EXTREMITY DEEP VEIN THROMBOSIS (DVT)
上肢深静脉血栓 (DVT) 的治疗
- 批准号:
7203336 - 财政年份:2005
- 资助金额:
$ 1.22万 - 项目类别:
Treatment of Upper Extremity Deep Vein Thrombosis (DVT)
上肢深静脉血栓 (DVT) 的治疗
- 批准号:
6981284 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
MANAGEMENT OF PATIENTS WITH SUSPECTED PULMONARY EMBOLISH
疑似肺栓塞患者的处理
- 批准号:
6499110 - 财政年份:2001
- 资助金额:
$ 1.22万 - 项目类别:
MANAGEMENT OF PATIENTS WITH SUSPECTED PULMONARY EMBOLISH
疑似肺栓塞患者的处理
- 批准号:
6703725 - 财政年份:2001
- 资助金额:
$ 1.22万 - 项目类别:
MANAGEMENT OF PATIENTS WITH SUSPECTED PULMONARY EMBOLISH
疑似肺栓塞患者的处理
- 批准号:
6258621 - 财政年份:2001
- 资助金额:
$ 1.22万 - 项目类别:
相似海外基金
Comparative Effectiveness of Enoxaparin vs. Dalteparin for Thromboprophylaxis Aft
依诺肝素与达肝素用于血栓预防的比较效果
- 批准号:
8784363 - 财政年份:2014
- 资助金额:
$ 1.22万 - 项目类别:
MULTI-DOSE PHARMACOKINETIC STUDY OF DALTEPARIN IN HEMODIALYSIS PATIENTS
达肝素在血液透析患者中的多剂量药代动力学研究
- 批准号:
7198473 - 财政年份:2005
- 资助金额:
$ 1.22万 - 项目类别:
Pharmacokinetic Study of Dalteparin in Hemodialysis
达肝素在血液透析中的药代动力学研究
- 批准号:
6974042 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
DALTEPARIN VS UNFRACTIONATED HEPARIN: A COMPARISON OF COAGULATION ACTIVATION MR
达肝素与普通肝素:凝血激活的比较 MR
- 批准号:
7205325 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:














{{item.name}}会员




